bpc-157 onset of effects timeline Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or How Do You Take BPC-157?
Description
If side effects are bad or you dont feel that the drug is effective, you may need a change in your dosage or the type of medication

IM methods provide slower, more stable uptake

AOD-9604 and Tesamorelin are the best-studied peptides for fat loss without appetite suppression
The peptide mobilizes fat, but you need to burn it through activity
